In the present study, we have uncovered a subset of DCIS that are ER negative and CT positive and which therefore may highlight a group which on further study may be more prone to recur and therefore become candidates for immunotherapeutic approaches to avoid progression into invasive breast cancer. Here, ESR1 is linked to invasive breast carcinoma.